ADILEN DILLINGHAM: Open Payments
NPI 1366656688 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 89 payments from 15 companies in 2025. Trend: 2023 $2,654 · 2024 $2,488 · 2025 $1,735
Food & beverage: $1,735
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $338 |
| PFIZER INC. | 17 | $259 |
| ABBVIE INC. | 11 | $201 |
| Galderma Laboratories, L.P. | 8 | $179 |
| Regeneron Healthcare Solutions, Inc. | 7 | $144 |
| LEO Pharma Inc. | 9 | $144 |
| Janssen Biotech, Inc. | 10 | $136 |
| Lilly USA, LLC | 6 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| UCB, Inc. | 2 | $41 |
Products named: DUPIXENT, CIBINQO, NEMLUVIO, ADBRY, SKYRIZI, TREMFYA, TALTZ, COSENTYX.
Industry payments across FL — which companies pay providers there.
